Detalhe da pesquisa
1.
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
N Engl J Med
; 385(24): e84, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614326
2.
Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
Clin Infect Dis
; 2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271690
3.
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.
Liver Transpl
; 28(2): 215-223, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767690
4.
Long-term complications associated with the management of sinonasal malignancies: a single center experience.
Acta Otorhinolaryngol Ital
; 43(3): 203-211, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204845
5.
Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders.
PLoS One
; 18(5): e0284925, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126496
6.
Recurrence Patterns and Efficacy of Surveillance Modalities for Sinonasal Malignancies.
Am J Rhinol Allergy
; 36(4): 473-479, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238217
7.
Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers.
Infect Control Hosp Epidemiol
; 43(10): 1433-1438, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551833
8.
Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours.
Eur J Cancer
; 168: 51-55, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439660
9.
Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy - a single centre prospective study.
Eur J Cancer
; 157: 124-131, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508994
10.
Letter of response to comment on: Efficacy and safety of BNT162b2 vaccination in solid cancer patients receiving anti-cancer therapy - A single centre prospective study.
Eur J Cancer
; 160: 285-286, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840027